Skip to main content
logo
Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
0.1727
+0.0041 (2.43%)
At close: Sep 2, 2026, 4:00 PM EDT
0.1696
-0.0031 (-1.80%)
Pre-market: Sep 3, 2026, 8:30 AM EDT

Vivos Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-25.46-21.17-11.14-13.58-23.85-20.29
Depreciation & Amortization
1.791.310.580.620.670.73
Loss (Gain) From Sale of Assets
----0.04-
Stock-Based Compensation
0.890.660.791.843.112.91
Other Operating Activities
-0.27-0.060.01-3.69-1.270.88
Change in Accounts Receivable
0.2-0.22-0.230.260.750.23
Change in Accounts Payable
1.180.52-1.050.730.490.14
Change in Unearned Revenue
0.1-0.51-1.43-0.610.64-0.54
Change in Other Net Operating Assets
4.444.2-0.232.49-0.160.2
Operating Cash Flow
-17.13-15.26-12.69-11.95-19.59-15.74
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1.88-2.34-0.57-0.85-0.92-2.4
Cash Acquisitions
-0.05-5.19----0.23
Other Investing Activities
-----0.01
Investing Cash Flow
-1.93-7.53-0.57-0.85-0.92-2.61

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-10.67----
Long-Term Debt Repaid
--0.03----0.03
Net Debt Issued (Repaid)
2.7810.65----0.03
Issuance of Common Stock
13.238.7519.2412-27.93
Other Financing Activities
-0.68-0.84-1.36-1.08--2.24
Financing Cash Flow
16.4418.5617.8810.92-24.17

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-2.63-4.234.62-1.88-20.515.82

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-19.01-17.6-13.26-12.8-20.51-18.13
Free Cash Flow Growth
------
Free Cash Flow Margin
-90.96%-100.92%-88.21%-92.74%-128.00%-107.38%
Free Cash Flow Per Share
-1.36-1.71-2.64-10.50-22.28-21.35
Levered Free Cash Flow
-8.53-9.41-8.84-8.61-11.25-11.27
Unlevered Free Cash Flow
-7.16-9.41-8.84-8.61-11.25-11.26

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.57-0.01--0.02
Change in Working Capital
5.924-2.942.861.710.03
SEC Filings: 10-K · 10-Q